ImmuneMed
Total Raised
$36.65MDeal Terms
2ImmuneMed Funding, ImmuneMed Valuation & ImmuneMed Revenue
6 Fundings
ImmuneMed's latest funding round was a Series D for $10.16M on November 3, 2021.
ImmuneMed's valuation in July 2018 was $88.08M.
ImmuneMed's latest post-money valuation is from July 2018.
Sign up for a free trial to see ImmuneMed's valuations in October 2017 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/3/2021 | Series D | $10.16M | 1 | |||
4/5/2019 | Series C | |||||
7/23/2018 | Series B - II | ▲$88.08M | ||||
10/19/2017 | Series B | |||||
4/14/2016 | Series A - II |
Date | 11/3/2021 | 4/5/2019 | 7/23/2018 | 10/19/2017 | 4/14/2016 |
|---|---|---|---|---|---|
Round | Series D | Series C | Series B - II | Series B | Series A - II |
Amount | $10.16M | ||||
Investors | |||||
Valuation | ▲$88.08M | ||||
Revenue | |||||
Sources | 1 |
ImmuneMed Deal Terms
2 Deal Terms
ImmuneMed's deal structure is available for 2 funding rounds, including their Series B - II from July 23, 2018.
Round | Series B - II | Series B |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B - II | |||||||||||||||
Series B |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.